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Division of Basic Biomedical Sciences, Sanford School of Medicine, The University of South Dakota, Vermillion, SD, USA
Chlamydia grows within a membrane-bound vacuole termed an inclusion. The cellular
processes that support the biogenesis and integrity of this pathogen-specified parasitic
organelle are not understood. Chlamydia secretes integral membrane proteins called
Incs that insert into the chlamydial inclusion membrane (IM). Incs contain at least two
hydrophobic transmembrane domains flanked by termini, which vary in size and are
exposed to the host cytosol. In addition, Incs are temporally expressed during the
chlamydial developmental cycle. Data examining Inc function are limited because of (i)
the difficulty in working with hydrophobic proteins and (ii) the inherent fragility of the
IM. We hypothesize that Incs function collaboratively to maintain the integrity of the
chlamydial inclusion with small Incs organizing the IM and larger Incs interfacing with host
cell machinery. To study this hypothesis, we have adapted a proximity-labeling strategy
using APEX2, a mutant soybean ascorbate peroxidase that biotinylates interacting and
proximal proteins within minutes in the presence of H2O2 and its exogenous substrate,
biotin-phenol. We successfully expressed, from an inducible background, APEX2 alone,
or fusion proteins of IncATM (TM = transmembrane domain only), IncA, and IncF
with APEX2 in Chlamydia trachomatis serovar L2. IncF-APEX2, IncATM-APEX2, and
IncA-APEX2 localized to the IM whereas APEX2, lacking a secretion signal, remained
associated with the bacteria. We determined the impact of overexpression on inclusion
diameter, plasmid stability, and Golgi-derived sphingomyelin acquisition. While there was
an overall impact of inducing construct expression, IncF-APEX2 overexpression most
negatively impacted these measurements. Importantly, Inc-APEX2 expression in the
presence of biotin-phenol resulted in biotinylation of the IM. These data suggest that Inc
expression is regulated to control optimal IM biogenesis. We subsequently defined lysis
conditions that solubilized known Incs and were compatible with pulldown conditions.
Importantly, we have created powerful tools to allow direct examination of the dynamic
composition of the IM, which will provide novel insights into key interactions that promote
chlamydial growth and development within the inclusion.
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INTRODUCTION
Chlamydia is an obligate intracellular bacterium and major
pathogen of humans. C. trachomatis (Ctr) serovars cause either
blinding trachoma (Schachter, 1999) or the most common
bacterial sexually transmitted infection (STI) (Datta et al., 2007).
It is estimated that 70% of primary chlamydial infections
in women are asymptomatic in keeping with the ability of
the pathogen to limit typical host inflammatory responses to
infection (Darville and Hiltke, 2010). As a consequence, these
infections may ascend from the cervix into the upper genital tract
potentiating the development of pelvic inflammatory disease,
ectopic pregnancy, and/or infertility. Highlighting the long-term
significance of these issues are CDC estimates indicating that
10% of women between the ages of 15 and 19 will test positive
for Chlamydia (Centers for Disease Control and Prevention,
2013). Further, the CDC calculates the cost of treating chlamydial
genital infections and associated conditions in the U.S. exceeds
700 million dollars annually (Satterwhite et al., 2011).
Intracellular survival and the ability to limit host response to
infection are linked to the intracellular lifestyle of Chlamydia and
its developmental program within the confines of an intracellular
vacuole, termed an inclusion. The developmental cycle is
initiated when metabolically quiescent elementary bodies (EBs)
are engulfed by cervical epithelial cells and differentiate within
an inclusion into non-infectious, metabolically active reticulate
bodies (RBs). Within the inclusion, the RBs create progeny via a
newly described polarized budding mechanism (AbdelRahman
et al., 2016). The completion of the developmental cycle is
marked by an asynchronous differentiation of RBs into infectious
EBs (see AbdelRahman and Belland, 2005 for review). The two
forms of Chlamydia reflect their distinct roles: the EB efficiently
mediates attachment and internalization into a susceptible host
cell (thereby limiting exposure to professional phagocytes),
and the RB, from within the inclusion, effectively orchestrates
intracellular host-chlamydial interactions to efficiently harvest
nutrients supporting the development of the inclusion and
creation of progeny.
The inclusion membrane simultaneously functions in two
distinct capacities. Firstly, it provides a barrier protecting
Chlamydia from intracellular host cell defenses. Secondly, it
creates a platform to support host-chlamydial interactions. The
development of the chlamydial inclusion membrane follows
the intra-inclusion progression of Chlamydia through the
developmental cycle. While existing type III secretion effectors
within the EB instigate entry into epithelial cells, proper inclusion
development requires de novo chlamydial protein synthesis
within the first 2 h of infection (Scidmore et al., 2003).
Specifically, chlamydial protein synthesis is required to make
newly translated type III effector proteins that function to
remodel the inclusion membrane within the first few hours post-
infection (Fields et al., 2003). An important class of chlamydial
type III secretion effectors is classified as Incs. Incs are proteins
that encode at least two transmembrane domains, which are
flanked by termini that are exposed on the host cytosolic face of
the chlamydial inclusion (Rockey et al., 1997; Bannantine et al.,
1998; Scidmore-Carlson et al., 1999; Dehoux et al., 2011; Lutter
et al., 2012). Highlighting their importance to the chlamydial
intracellular lifestyle, Ctr encodes greater than 50 inc genes,
which represents 6% of the total coding capacity of a highly
reduced genome (Stephens et al., 1998). Incs are expressed and
inserted into the inclusion membrane in temporally defined
patterns (Shaw et al., 2000; Gauliard et al., 2015), suggesting
that Incs play specific roles within the inclusion membrane at
specific stages of the chlamydial developmental cycle (Moore and
Ouellette, 2014).
The proposed function of Incs is articulated on a theoretical
level only. Data on their specific function in the chlamydial
inclusion membrane are limited due to the difficulty in working
with proteins with large hydrophobic regions. In the field, it is
widely accepted that Incs serve to interact with host machinery,
and the limited data seemingly support this idea (Scidmore and
Hackstadt, 2001; Rzomp et al., 2006; Alzhanov et al., 2009; Derre
et al., 2011; Lutter et al., 2013; Dumoux et al., 2015; Kokes
et al., 2015; Mital et al., 2015). Some Incs contain cytosolic
domains between 60 and 200 amino acids in size, and such
structured domains would certainly support interactions with
eukaryotic host proteins. Other Incs contain cytosolic domains
with less than 30 amino acids in size, which creates less feasible
targets for eukaryotic proteins. Recent data demonstrate that
specific Incs may also interact with one another and colocalize
into “membrane microdomains” within the inclusion membrane
(Mital and Hackstadt, 2011; Weber et al., 2015). Further, a
bacterial two-hybrid (BACTH) system determined that certain
Incs, like IncF, have the ability to homodimerize and also
interact extensively with other Inc proteins (Gauliard et al., 2015).
Inclusion engagement of specific host pathways is necessary
for avoidance of fusion with lysosomes, avoidance of other
innate immune defenses, and selective interaction with specific
host pathways for nutrient acquisition (Hackstadt et al., 1996;
Scidmore et al., 1996; Rzomp et al., 2003, 2006; Beatty, 2006;
Moore et al., 2008, 2011; Ouellette and Carabeo, 2010; Ouellette
et al., 2011; Kabeiseman et al., 2013; Lucas et al., 2015). Two
recent studies worked toward identifying inclusion interactomes
and identified new host protein-Inc interactions (Aeberhard
et al., 2015; Mirrashidi et al., 2015). However, neither study
demonstrated Inc-Inc interactions, and Mirrashidi et al. did not
examine Inc protein interactions in the context of a chlamydial
infected cell. Therefore, how Incs are organized in the inclusion
membrane to maximize necessary contacts with the host cell is
completely unknown.
We hypothesize that Incs collaboratively function to maintain
the integrity of the chlamydial inclusion with small Incs
organizing the chlamydial inclusion membrane and larger Incs
interfacing with host cell machinery. To test this hypothesis,
we need to determine protein-protein interactions within the
context of the chlamydial inclusion membrane in an infected
cell. This strategy will require circumventing the incompatibility
of cell lysis strategies with conditions that effectively solubilize
hydrophobic proteins. Therefore, for these studies, we employed
a proximity labeling technique combined with the recent ability
to transform Chlamydia. APEX2 is a mutant soybean ascorbate
peroxidase that can be genetically fused to a protein of interest
to biotinylate interacting and proximal proteins (≤20 nm) after
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 2 February 2017 | Volume 7 | Article 40
Rucks et al. Mapping the Chlamydial Inclusion
addition of its exogenous substrate, biotin-phenol, and catalysis
of the reaction with H2O2 (Rhee et al., 2013). APEX2 targets
electron-rich amino acids, such as tryptophan, tyrosine, histidine,
and cysteine (Rhee et al., 2013). Biotinylation of subcellular
structures, such as the inclusion membrane, can be monitored
by microscopy. Further, purification of proximal or interacting
proteins relies on the affinity and avidity of streptavidin for
biotin. For this study, we have created Inc-APEX2 constructs
and used them to examine the impact of overexpression of an
early Inc (IncF) on inclusion development. We also present data
demonstrating our ability to solubilize the chlamydial inclusion
membrane and perform a subsequent pulldown. Importantly,
completion of these studies will help us to determine specific
roles for Inc proteins in the biogenesis and maintenance of the
chlamydial inclusion membrane.
MATERIALS AND METHODS
Organisms and Cell Culture
HeLa 229 cells [American Type Culture Collection (ATCC);
Manassas, VA; CCL-2.1] were cultured at 37◦C with 5%
CO2 in biotin-free DMEM (HyClone/Thermo Scientific, Logan,
UT) supplemented with 10% (routine culture) or 1% fetal
bovine serum (experiments involving biotinylation) (FBS;
HyClone) as indicated and 10 µg/ml gentamicin (Gibco-
BRL/Life Technologies; Grand Island, NY). HeLa cells were
used to propagate Chlamydia trachomatis serovar L2 (LGV 434)
for purification using established protocols (Caldwell et al.,
1981; Scidmore, 2005). Chlamydial titers were determined using
conventional protocols to establish multiplicities of infection
(m.o.i.), which are based on inclusion forming units (i.f.u.) and
determined in HeLa cells as previously described (Furness et al.,
1960; Scidmore, 2005). HeLa cells and density-gradient purified
C. trachomatis strains are routinely tested forMycoplasma spp.
Creation of Inc-APEX2 Constructs
All primers used in these cloning projects are listed in Table 1.
pcDNA3 APEX2-NES was a gift from Alice Ting (Addgene
plasmid # 49386) (Lam et al., 2015). APEX2 contains a single N-
terminal FLAG tag. To generate Inc-APEX2 fusion constructs,
PCR was used to introduce restriction sites. Q5 site-directed
mutagenesis (NEB, Ipswich, MA) was used to remove an
internal AgeI site by creating a synonymous mutation in APEX2.
The PCR products were cloned in frame into the gfp site of
pASK_GFP_mKate2_L2 (pASK_L2) (kind gift of Dr. P. Scott
Hefty, Wickstrum et al., 2013) to create IncF-APEX2, IncATM-
APEX2, IncAFL-APEX2 and APEX2 only constructs (schematic
of constructs found in Supplemental Figure 1) using previously
described conditions (Moore et al., 2011; Ouellette et al., 2015).
Final constructs were transformed into dam-/dcm- E. coli.
All constructs were confirmed by sequencing (Eurofins MWG
Operon, Hunstville, AL).
Chlamydial Transformation
Transformations were performed as described previously (Wang
et al., 2011; Mueller and Fields, 2015; Ouellette et al., 2015).
Transformants were then plaque purified as described elsewhere
TABLE 1 | Primers used for construction of Inc-APEX2.
Primer sequence Purpose
ggACCGGTATGACAACGCCTACT
CTAATCG
Cloning IncATM into vector 5’AgeI site
ggggGGATCCATTAATTTCTT
TTAGAGACCCAACTT
Cloning IncATM into vector 3’ BamHI site
ggACCGGTATGGGAGACG
TAATGATACAGAGCG
Cloning IncF into vector with 5’ AgeI site
ggggGGATCCGCACTTATTTGTA
GAAGCGAT
Cloning IncF into vector with 3’ BamHI site
CCTTCGGAACCATCAAGCACCC
TGCCGA
Samesense mutation to remove AgeI sites
from APEX2 using Q5 mutagenesis
GTCCGCCTGTCTTCGTGCCCTTGT
CAAAG
Samesense mutation to remove AgeI sites
from APEX2 using Q5 mutagenesis
GGGCGGCCGctattaGTCCAGGGTC
AGGCG
Cloning APEX2 into vector 3’ EagI site
ggggACCGGTatggactacaaggatga
cgacg
Cloning APEX2 into vector 5’AgeI site
ggACCGGTATGACAACGCCTACTC
TAATCG
Cloning IncA into vector 5’ AgeI site
ggggGGATCCGGAGCTTTTTG
TAGAGGGTGAT
Cloning IncA into vector 3’ BamHI site
Underlined sequences denote restriction sites.
(Matsumoto et al., 1998; Wang et al., 2011). Localization of
IncF-APEX2, IncATM-APEX2, or APEX2 in chlamydiae was
performed by plating HeLa cells on coverslips in a 24-well plate
at 1 × 105 per well and infecting with the transformed strain
in the presence of 2 U/mL penicillin (IncF-APEX2, IncATM-
APEX2) or 1 U/mL penicillin (IncAFL-APEX2, APEX2) and 1
µg/mL cycloheximide. Penicillin and cycloheximide were present
for all experiments to preserve the integrity of our transformants
and to minimize host cell background, respectively. At 7 h post-
infection (hpi), varying concentrations of anhydrotetracycline
(aTc) were added and samples were fixed at the indicated times in
methanol for 5 min at room temperature and stained by indirect
immunofluorescence.
Indirect Immunofluorescence Microscopy
HeLa cells were seeded onto 12 mm coverslips 18 h before
infection with appropriate Ctr serovar L2 transformant or
wild type bacteria. At indicated times post-infection, following
5 min methanol fixation, coverslips were incubated with
antibodies in Table 2 to visualize construct expression (mouse
anti-M2-FLAG), the inclusion membrane (rabbit anti-IncA),
and organisms (guinea pig anti-Ctr L2, rabbit anti-Ctr L2),
followed by incubation with the appropriate secondary antibody
conjugated to DyLight fluors (Jackson ImmunoResearch
Laboratories; West Grove, PA). Biotinylated proteins were
detected using streptavidin conjugated to Alexa Fluor 488
(Pierce/Thermo, Rockford, IL). Coverslips were mounted on
glass microscope slides using Prolong Gold mounting reagent
(Life Technologies). Images were acquired using an Olympus
BX60 with a 40x or 60x objective and a Nikon DS-Qi1MC digital
camera or Olympus Fluoview 1000 Laser Scanning Confocal
Microscope (60x objective and 2x digital magnification).
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TABLE 2 | Antibodies used for indirect immunofluorescence and Western
blotting.
Antibodies Source Immunofluorescence Western
blotting
mouse anti-FLAG M2 Sigma X
rabbit anti-IncA Ted Hackstadta X X
guinea pig anti- C.
trachomatis L2
Ted Hackstadta X
rabbit anti-C.
trachomatis L2
Ted Hackstadta X
mouse anti-α-tubulin Cell Signaling X
mouse anti-GM130 BD Transduction X
mouse anti-C.
trachomatis Hsp60
Rick Morrisonb X
aKindly provided by Ted Hackstadt, NIAID, Rocky Mountain Laboratories, Hamilton, MT.
bKindly provided by Rick Morrison, University of Arkansas Medical Center, Little Rock, AR.
Determination of Inclusion Diameter
HeLa cell monolayers were infected (m.o.i. 0.8) with Ctr
serovar L2 transformants encoding IncF-APEX2, IncATM-
APEX2, APEX2 or wild type bacteria by centrifugation at
400 × g for 15 min at room temperature (RT) in DMEM
supplemented with 1% FBS containing 2 U/mL penicillin (Ctr
L2 IncF-APEX2 and Ctr L2 IncATM APEX2) or 1 U/mL
penicillin (Ctr L2 APEX2) and 1 µg/mL cycloheximide and
then incubated at 37◦C, 5% CO2. At 7 hpi, transformants were
either induced or not with 0.1 or 5 nM aTc. After 36 hpi, cells
were fixed as above and coverslips were processed for indirect
immunofluorescence. Inclusion diameter was measured using
NIS elements Basic Research version 3.22 software (Nikon). Data
shown are representative of two independent experiments where
a minimum of 100 inclusions/coverslip were evaluated. Inclusion
diameter mean and standard error of the mean were graphed
using GraphPad Prism 7.0a. A one-way ANOVA with Tukey’s
multiple comparisons test was performed to test for statistical
significance.
Determination of Plasmid Retention
HeLa cells were infected with Ctr L2 transformants encoding
IncF-APEX2, IncATM-APEX2 or APEX2 as above. Expression of
the APEX2 fusion proteins (or APEX2 alone) was induced for
expression or not in the transformants with 0.1, 1, or 5 nM aTc
in duplicate at 7 hpi. To visualize inclusion formation, at 24 hpi
one replicate was fixed and processed for immunofluorescence
to detect construct expression, chlamydial inclusions, and
organisms. Infectious progeny produced were harvested at 24
hpi from duplicate wells, centrifuged 20,000 × g for 30 min,
and serial dilutions in sucrose phosphate (2SP) buffer were re-
infected onto HeLa cells in duplicate, essentially as previously
described (Kabeiseman et al., 2013; Lucas et al., 2015). Cells were
incubated at 37◦C, 5% CO2 for 15 min, then 2SP was replaced
with DMEM + 1% FBS containing 2 U/mL penicillin (Ctr L2
IncF-APEX2 and IncATM-APEX2) or 1 U/mL penicillin (Ctr
L2 APEX2 only) and 1 µg/mL cycloheximide. At 24 h post-
secondary infection, cells were fixed in methanol and processed
for indirect immunofluorescence with rabbit or guinea pig anti-
Ctr L2 to distinguish aberrant vs. normal organisms. Aminimum
of 100 inclusions was counted per coverslip and averaged.
Three individual experiments were performed for each dataset,
except for 1 nM aTc induction, which was performed as two
separate experiments only. The percent of inclusions containing
aberrant organisms out of total number of inclusions counted
was plotted using GraphPad Prism ver. 7.0a and reported as
mean and standard error of the mean. A two-way ANOVA with
Tukey’s multiple comparisons post-test was performed to test for
statistical significance.
Live Cell Imaging
HeLa cells were infected with Ctr L2 transformants encoding
IncF-APEX2, IncATM-APEX2 as above. Transformants were
either induced or not with 0.1 or 5 nM aTc at 7 hpi. 1.5 h prior
to imaging, cells were labeled with 1 µM 6-((N-(7-nitrobenz-
2-oxa-1, 3-diazol-4-yl)amino)hexanoyl)sphingosine (C6-NBD-
ceramide); (Life Technologies) in DMEM +0.06% BSA for
20 min at 37◦C, and excess label was removed via back-
exchange with DMEM containing 0.6% BSA for an hour at 37◦C
as described previously (Hackstadt et al., 1995; Moore, 2012;
Kabeiseman et al., 2013; Lucas et al., 2015). Fluorescent live
cell images were acquired by mounting the coverslips onto glass
slides, as previously described (Moore, 2012), and imaging at 30-
40 ms exposure times with a Nikon DS-Qi1Mc camera mounted
on an Olympus BX60 fluorescent scope (60x magnification).
Seven to ten fields of view were taken from duplicate coverslips
in two independent experiments. The fluorescent intensity
(integrated density) and area of the inclusion were determined
with ImageJ v1.48 (National Institutes of Health, Bethesda, MD).
Mean and standard error of the mean were calculated and
graphed using GraphPad Prism 7.0a software. An ordinary one-
way ANOVA with Tukey’s multiple comparisons post-hoc test
was performed to test for statistical significance.
Labeling Cells with Biotin-Phenol and
Affinity Purification of Biotinylated Proteins
For microscopic confirmation of Inc-APEX2 constructs’ ability
to biotinylate the inclusion membrane, HeLa cells plated in 24-
well plates were infected with Ctr L2 transformants (m.o.i. 0.8)
as above in DMEM supplemented with 1% FBS. HeLa cells
were grown in biotin-free media (DMEM + 1% FBS) prior to
infection. Ctr L2 IncF-APEX2 and IncATM-APEX2 were induced
with aTc at 7 hpi. At 23.5 hpi, labeling was performed essentially
as previously described (Martell et al., 2012; Lam et al., 2015),
and at 24 hpi, coverslips were fixed and processed for indirect
immunofluorescence.
To determine proteins that were biotinylated by IncF-APEX2,
HeLa cells were seeded into a 6-well plate in DMEM + 1% FBS
and allowed to grow overnight. To monitor construct expression
and biotinylation, coverslips are placed in 2 out of 6 wells of the
6-well plate. The cells were infected with Ctr L2 IncF-APEX2
(m.o.i. 0.75) and induced with 0.2 nM aTc at 7 hpi. At 23–
26 hpi, 150 µM clastolactacystin β-lactone (clastolactacystin)
(Santa Cruz biotechnology, Dallas, TX) (Johnson et al., 2015)
was added to each well, and plates were incubated at 37◦C 5%
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CO2 for an additional 30 min prior to biotinylation: at 23.5–
26.5 hpi, monolayers were incubated with 1.5 mM biotinyl-
tryamide (aka biotin-phenol) (AdipoGen, San Diego, CA) for 30
min at 37◦C and 5% CO2. At 24–27 hpi, the labeling process
was catalyzed by the addition of 3 mM H2O2 in DPBS for 1
min at RT with gentle rocking. The reaction was quenched by
3 washes at room temperature with 10 mM sodium ascorbate,
10 mM sodium azide, and 5 mM Trolox, all in DPBS. Coverslips
were removed and fixed, and remaining cells were scraped into
DPBS and centrifuged at 700 × g for 10 min at 4◦C, and
the pelleted cells were resuspended in cell lysis buffer [50 mM
TrisHCl, pH 7.4, 150 mM NaCl, 0.5% sodium deoxycholate, 10
mM sodium ascorbate (Sigma), 10 mM sodium azide (Sigma), 5
mM trolox (Acros organics), 1% sodium dodecyl sulfate (SDS),
5% TritonX-100 (Sigma Aldrich), 1X HALT protease inhibitor
cocktail (Pierce/Thermo), universal nuclease (Pierce), and 150
µM clastolactacystin (Santa Cruz biotechnology, Dallas, TX).
Samples were sonicated three times at 30% amplitude for 20 sec
and incubated on ice for 90 min, vortexing every 15 min. Lysates
were centrifuged at 14,000 × g for 10 min at 4◦C. Supernatants
were saved, and pellets were resuspended in the cell lysis buffer
described above.
Protein concentrations were quantified prior to affinity
purification using EZQ protein quantification (Life technologies,
Molecular probes) and normalized. Normalized lysates were
added to equilibrated streptavidin magnetic beads (Pierce) and
rotated for 90 min at RT. Unbound fractions of the lysate were
retained and beads were washed twice by rotating with lysis
buffer containing 500 mM NaCl for 5 min at RT, followed by
one wash with 2 M urea in 10 mM Tris-HCl pH 8.0 and 2
washes with RIPA buffer. Proteins were eluted from streptavidin
magnetic beads by 5 min denaturation at 65◦C in 2x Laemmli
sample buffer containing 0.5 mM biotin (Sigma). Samples were
resolved by SDS-4-20%PAGE (BioRad), followed by transfer
to PVDF (0.45 µm, Thermo Scientific) and Western blotting
using the indicated primary antibodies (Table 2) and appropriate
secondary antibodies conjugated to IRDye 680LT, IRDye CW,
or a streptavidin-IRDye 680LT conjugate (LiCor Biosciences,
Lincoln, NE). PVDF membranes were imaged using Odyssey
CLx and processed using Image Studio version 5.2 (LiCor
Biosciences). After Western blotting, some PVDF membranes
were also Coomassie stained using the following protocol.
Membranes were rinsed with 100% methanol followed by one
wash in Tris-buffered saline with 0.1% tween 20 (TBS-T) for 5
min at RT. Membranes were stained with Coomassie Brilliant
Blue R-250 (BioRad) for 2.5 min at RT and then destained
with two consecutive washes of 50:43:7, methanol:dH2O:acetic
acid and 90:10 methanol: acetic acid, respectively. Air-dried
membranes were imaged using GeneSnap software (SynGene).
Densitometry and Image Production
All Western blots were analyzed using Image Studio Version
5.2 software (LiCor Biosciences). Graphed data (averages and
standard deviation or standard error of the mean) were produced
using GraphPad Prism 7 software (GraphPad Software, La
Jolla, CA). All figures were constructed using Adobe Photoshop
elements 14 and Adobe Photoshop CS5 (Adobe Systems
Incorporated, San Jose, CA). Any modifications to images were
limited to adjustment of color balance in fluorescent images, or
brightness and contrast in Western blot images. The inclusion
sizes were measured using NIS elements basic research Version
3.22 (Nikon).
RESULTS
Expression of APEX2 Constructs from Ctr
Serovar L2
To better understand the function of Incs in the context of
the chlamydial inclusion, we created tools that would allow the
identification of interacting and proximal proteins by fusing
a target Inc to APEX2 (Supplemental Figure 1). Incs are type
III secreted proteins with the secretion signal located at the
N-terminus; therefore, we initially verified that Inc-APEX2
constructs localized correctly to the chlamydial inclusion. In
selecting which Incs to apply in these studies, we focused on
IncF because of data illustrating that IncF interacts with other
Inc proteins in a bacterial two-hybrid system (Gauliard et al.,
2015), thus giving us the opportunity/potential to capture Inc-
Inc interactions. In contrast, IncA was chosen because it is
the best studied of all Incs (Rockey et al., 1997; Bannantine
et al., 1998; Hackstadt et al., 1999; Delevoye et al., 2004;
Suchland et al., 2008; Johnson and Fisher, 2013; Ronzone
and Paumet, 2013; Weber et al., 2016), thus making it a
good candidate to help develop a new system for examining
both host and bacterial protein interactions at the inclusion
membrane. For these studies, we transformed Ctr serovar L2
with the pASK_L2 plasmid containing either APEX2 alone,
IncAFL-APEX2 (full length IncA), IncATM-APEX2 (lacking
the C-terminal cytosolic domain of IncA), and IncF-APEX2
(schematic provided in Supplemental Figure 1). HeLa cells were
inoculated with the purified chlamydial transformants and
expression of the constructs was induced 7 h post-infection
with the indicated concentrations of anhydrotetracyline (aTc)
(Figure 1 and Supplemental Figure 2). Cells were fixed at 24
h post-infection to monitor expression and localization of the
construct in infected cells by immunofluorescence. Expression
of the APEX2 only construct resulted in the protein remaining
localized within chlamydial organisms (Figure 1A). In contrast,
all Inc-APEX2 constructs localized to the chlamydial inclusion
membrane (Figures 1B,C and Supplemental Figure 2). These
results indicate that addition of APEX2 to the C-terminus of
Inc proteins does not interfere with their type III secretion from
Chlamydia or with their ability to localize to the chlamydial
inclusion membrane.
Initially, we tested expression of our APEX2 constructs
from Chlamydia with 5 nM aTc. However, when we examined
the expression of IncF-APEX2 under these conditions, we
noticed several phenomena: the formation of smaller inclusions,
the development of aberrant organisms within the inclusions
(presumably as a result of the chlamydial transformants losing
the plasmid during the experiment), and the consolidation of
IncF in small foci at the edges or outside of the inclusion.
Further, “normal” sized inclusions also typically harbored
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FIGURE 1 | Induction of expression of APEX2 constructs from
transformed Ctr L2. Ctr L2 was transformed with anhydrotetracycline
(aTc)-inducible chlamydial expression vector pASK-L2 vector containing
APEX2 (A), IncATM-APEX2 (TM = transmembrane domain only) (B), or
IncF-APEX2 (C). HeLa cells were infected as described in Materials and
Methods, and expression of constructs was induced 7 h post-infection with
the indicated concentrations of aTc. Infected monolayers were fixed in
methanol and processed for indirect immunofluorescence to detect expression
of the construct with anti-FLAG antibody (red), the inclusion membrane with an
anti-IncA antibody (green), or chlamydial organisms with an anti-Ctr L2
antibody (blue). Details for primary antibodies used in this study are found in
Table 2. After incubation with the appropriate secondary antibodies,
coverslips were mounted. Images were taken with Olympus Fluoview 1000
Laser Scanning Confocal Microscope (60x magnification with 2x zoom). Scale
bars equal 10 µm; “a” indicates inclusions with aberrant bacteria; white arrows
point to foci formed by secreted IncF-APEX2; the white asterisk indicates small
inclusion formed by organisms expressing IncF-APEX2.
aberrant Chlamydia, while smaller inclusions were formed by
organisms expressing the IncF-APEX2 construct on the inclusion
membrane (Figure 1C). Using lower concentrations of 0.1 nM
aTc, IncF-APEX2 localized uniformly around the chlamydial
inclusion (Figure 1C), as previously reported for endogenous
IncF localization (Scidmore-Carlson et al., 1999; Shaw et al.,
2000; Li et al., 2008). The exclusion of IncF-APEX2 at higher
concentrations of aTc seemed unique to this construct, as IncAFL-
APEX2 and IncATM-APEX2 did not produce excluded Inc foci,
even if expressed with 10 nM aTc (data not shown). Comparing
IncF and IncA, IncF is expressed early in the chlamydial
developmental cycle (Shaw et al., 2000) and has a small C-
terminal cytosolic domain of 14 amino acids. IncA is expressed
during the mid-chlamydial developmental cycle and has a much
larger 193 amino acid C-terminal cytosolic domain encoding
SNARE-like domains (Delevoye et al., 2008). The IncATM-
APEX2 construct contains only 27 amino acids of the C-terminal
domain fused to APEX2 (Supplemental Figure 1); given this
construct’s rim-like localization to the inclusion membrane
(Figure 1B), we conclude that shortened Inc C-terminal fusions
to APEX2 do not compromise the localization of these constructs.
In sum, these initial data indicated that overexpression of IncF
is not well tolerated by chlamydiae and compromises inclusion
development.
Effect of Overexpression of Inc-APEX2
Constructs on Inclusion Development
To quantify the effect of Inc-APEX2 expression on chlamydial
inclusion expansion, we infected HeLa cells with Ctr
serovar L2 that was not transformed (wild-type, WT) or
transformed with pASK_L2_APEX2, pASK_L2_IncF-APEX2, or
pASK_L2_IncATM-APEX2. Infected monolayers were treated
with the indicated amounts of aTc at 7 h post-infection to induce
the expression of the constructs. At 36 h post-infection, cells
were fixed and processed for indirect immunofluorescence to
detect expression of the construct, the chlamydial inclusion,
and chlamydial organisms. Inclusion diameter was measured
as described in Materials and Methods (Figure 2). Inclusions
that were excluded from calculations included inclusions
containing aberrant forms of Chlamydia and inclusions that had
excluded Inc-APEX2 (see IncF-APEX2 at 5 nM aTc, Figure 1C).
The diameters of inclusions formed at 36 h post-infection
by untransformed Ctr serovar L2 without or with aTc were
21.65 µm ± 0.228 and 21.22 µm ± 0.231, respectively. The
diameters of inclusions formed by chlamydial transformants
containing pASK_L2_APEX2, pASK_L2_IncF-APEX2, or
pASK_L2_IncATM-APEX2 were 19.22 µm ± 0.295, 21.55
µm ± 0.267, and 19.11 µm ± 0.239, respectively. These data
are consistent with transformed Chlamydia developing at a
slightly slower rate than non-transformed strains. Induction
of all constructs led to a decrease in the diameter of the
inclusions, indicating an overall metabolic impact related to
construct expression (Figure 2). On average, the inclusions
formed by Chlamydia expressing APEX2 and IncATM-APEX2
were statistically significantly decreased by ∼9 µm, with
diameters measuring 10.24 µm ± 0.218 and 12.76 µm ± 0.200,
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FIGURE 2 | Effect of APEX2 construct expression on inclusion diameter. HeLa cells were infected with Ctr L2 transformants (detailed on the x-axis) as in
Figure 1, and construct expression was induced with the indicated concentrations of anhydrotetracycline (aTc) at 7 h post-infection. Cells were fixed 36 h
post-infection, processed for indirect immunofluorescence, and inclusion diameters (expressed in µm, y-axis) were determined as in Materials and Methods. Data
shown include two independent experiments where 100 inclusions/coverslip were evaluated. Inclusion diameter mean and standard error of the mean are shown and
were graphed using GraphPad Prism 7.0. Statistical analysis of the data included a one-way ANOVA with Tukey’s multiple comparisons test; statistical significance is
shown with **** equaling p < 0.0001, and # equaling p < 0.0001 for all conditions specifically compared to IncF-APEX2 induced with 5 nM aTc.
respectively. The decrease of diameter associated with expression
of IncF-APEX2 was different depending on the amount of aTc
used to induce expression. Induction with 0.1 nM aTc caused a
statistically significant ∼3.14 µm reduction in diameter (15.97
µm± 0.431; p< 0.0001), while induction with 5 nM aTc caused a
statistically significant ∼13.8 µm decrease in inclusion diameter
(5.40 µm ± 0.165). Of note, the decrease in diameter caused by
expression of IncF-APEX2 with 5 nM aTc was also statistically
significant from expression of APEX2 alone, IncATM-APEX2
expressed with 5 nM aTc, and IncF-APEX2 expressed with 0.1
nM aTc. These data indicate that overexpression of IncF-APEX2
impairs inclusion membrane expansion above and beyond
what can be attributed to a metabolic cost of producing the
“exogenous” protein.
If overexpression of a specific construct created stress for
Chlamydia, then one response may be for the organism to
lose the plasmid and subsequently become morphologically
aberrant in the presence of penicillin (the selecting agent;
Supplemental Figure 3). To test for this occurrence, we infected
HeLa cells with purified chlamydial transformants of IncATM-
APEX2, IncF-APEX2, or APEX2 alone and induced expression
of the constructs with the indicated concentrations of aTc 7 h
post-infection. Of note, we have found that 0.1 nM aTc does not
induce detectable expression of the IncATM-APEX2 or APEX2
constructs (data not shown). At 24 h post-infection, monolayers
were lysed, and lysates were serially diluted and re-plated onto a
fresh monolayer of HeLa cells in medium containing penicillin,
which is the selectable antibiotic for the pASK-L2 plasmid
(Wickstrum et al., 2013). The cells were fixed, and inclusions
containing either normal ormorphologically aberrant chlamydial
forms were enumerated. Increasing concentrations of aTc did
not increase the numbers of inclusions with aberrant forms in
transformants of pASK_L2_IncATM-APEX2. The incidence of
plasmid loss in uninduced cultures was 1.542% ± 0.926, similar
to the incidence of plasmid loss after induction of expression
of the IncATM-APEX2 construct with 5 nM aTc, which was
0.836 ± 0.490 (Figure 3). However, increasing concentrations
of aTc did increase the numbers of inclusions bearing aberrant
chlamydial forms for transformants of pASK_L2_IncF-APEX2
and pASK_L2_APEX2 (Figure 3). The incidence of plasmid
loss in uninduced cultures of chlamydial transformants of
pASK_L2_IncF-APEX2 was 6.042 ± 2.059%. Of note, induction
of expression of IncF-APEX2 with 0.1 nM aTc, which results in
correct localization of the construct to the chlamydial inclusion
membrane (Figure 1C), did not cause a significant increase
in incidence of plasmid loss, with 7.440 ±1.428% (Figure 3).
However, at 1 nM or 5 nM aTc induction of IncF-APEX2, plasmid
loss increased with 60.538 ± 3.579% and 68.182 ± 8.055%
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FIGURE 3 | Effect of APEX2 construct expression during the primary infection on plasmid stability. HeLa cells were infected with Ctr L2 transformed
(detailed on the x-axis) as in Figure 1, and construct expression was induced with the indicated concentrations of anhydrotetracycline (aTc) at 7 h post-infection. At
24 h post-infection duplicate coverslips were either fixed to determine construct expression or lysed to release infectious chlamydial organisms to infect a fresh
monolayer (secondary infection) in the presence of penicillin to monitor retention of plasmid. Chlamydia that did not retain the expression plasmid would become
susceptible to penicillin and become morphologically aberrant. This morphological form is readily distinguished from normal chlamydial development forms by indirect
immunofluorescence microscopy. Treating Ctr L2 transformants of IncATM-APEX2 or APEX2 with 0.1 nM aTc did not result in construct expression, and, therefore,
these conditions were eliminated from analysis. 100 inclusions per coverslip were determined to contain either normal or aberrant Chlamydia (see
Supplemental Figure 3). This assay had three biological replicates within two independent experiments. Data are expressed as mean and standard error of the mean
of the percentage of inclusions containing aberrant organisms, were graphed, and statistically analyzed using GraphPad Prism 7.0 software. Data were analyzed for
statistical significance using two-way ANOVA with Tukey’s multiple comparisons post-test, and are indicated with **** for p < 0.0001, and *** for p < 0.001.
inclusions containing aberrant organisms, respectively. Plasmid
loss was also noted when APEX2 was expressed with 59.508 ±
4.125% and 83.678 ± 2.519% of inclusions harboring aberrant
Chlamydia after induction with 1 nM or 5 nM aTc, respectively.
Unlike IncATM-APEX2 or IncF-APEX2, which are secreted,
even at high concentrations of aTc, APEX2 remains within the
chlamydial organisms, thus potentially creating toxic conditions
directly in the bacteria. Therefore, the increase in plasmid loss
in chlamydial organisms expressing high levels of IncF-APEX2
or APEX2 only is likely creating unfavorable conditions but via
different mechanisms. Of note, the aTc concentrations associated
with plasmid loss in transformants expressing IncF-APEX2
were the same concentrations associated with exclusion and/or
aggregation of IncF-APEX2 from the inclusion (Figure 1C) and
statistically significant smaller inclusions (Figure 2).
Effect of Inc-APEX2 Expression on
Golgi-Derived Sphingomyelin Acquisition
Our combined data suggest that overexpression of IncF-
APEX2 negatively impacts chlamydial health by compromising
inclusion development. One metric for assessing normal
inclusion development is via its interactions with host cell
trafficking pathways. Chlamydiae selectively interact with
exocytic vesicles, and this can be tracked via acquisition of
fluorescent sphingomyelin. To ascertain if overexpression of
IncF-APEX2 inhibited acquisition of fluorescent sphingomyelin,
we performed live cell imaging and quantified the “brightness”
per area of inclusions harboring chlamydial transformants either
uninduced or induced to express IncF-APEX2, IncATM-APEX2,
or APEX2 only. Given the small size of IncF-APEX2 inclusions
formed after induction with 5 nM aTc, we also included a
comparison of inclusions formed at 14.5 h post-infection to
control for effects of inclusion size vs. effects of overexpression
of the construct. For these experiments, infected monolayers
were labeled with NBD-ceramide then back-exchanged for 1 h
prior to live-cell imaging, as described inMaterials and Methods.
As shown in the representative images in Figure 4A, 14.5 h
inclusions contain only RBs, which have previously been shown
to retain more sphingomyelin than inclusions with mixed RB
and EB populations, as in the 25 h post-infection images (Lucas
et al., 2015). Quantification of the images of uninduced samples
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FIGURE 4 | Effect of Inc-APEX2 expression on acquisition of Golgi-derived sphingomyelin. HeLa cells were infected with Ctr L2 transformants of
IncF-APEX2, IncATM-APEX2, and APEX2 only and construct expression was induced 7 h post-infection. Infected monolayers were labeled with NBD-ceramide and
back-exchanged to remove fluorescent lipid trafficked to the plasma membrane as described in Materials and Methods. Live cell images were taken at 14.5 or 25 h
post-infection using a 60x objective of an Olympus BX60 mounted with a Nikon DS-Qi1MC digital camera. Seven to ten fields of view were taken from duplicate
coverslips in two independent experiments, and integrated density (brightness resulting from acquisition of fluorescent sphingomyelin) and inclusion area values were
determined using ImageJ v1.48 software (National Institutes of Health, Bethesda, MD). Representative images of the matched graphed conditions are shown in (A).
Scale bars are equal to 5 µm, and white arrows indicate inclusions. In (B), the fluorescent intensities (integrated density) divided by the areas of individual inclusions
were graphed as mean and standard error of the mean using GraphPad Prism 7.0 software. Statistical significance was determined using an ordinary one-way
ANOVA with Tukey’s multiple comparisons post-test, with **** indicating p < 0.0001 and *** indicating p < 0.001. In statistical comparison of IncF-APEX2 induced
with 5 nM aTc imaged at 25 hpi with indicated data points, & specifies p < 0.001 and && specifies p <0.0001.
at 14.5 and 25 h post-infection show that 14.5 h inclusions
formed by Ctr transformed with pASK_L2_IncF-APEX2 or
pASK_L2_IncATM-APEX2 differ in “brightness” (arbitrary units
of integrated density) per inclusion area (30.60 ± 0.8382 and
21.68 ± 0.8355, respectively) than 25 h inclusions formed by
these same uninduced strains (35.16 ± 0.6173 and 36.79 ±
1.219) (Figure 4B). Induction of expression of IncF-APEX2 with
0.1 nM aTc resulted in slightly smaller inclusions (Figure 4A),
consistent with previous results, and an overall decrease in
fluorescent sphingomyelin retained by the inclusion (26.25 ±
0.5709), which was statistically significant (p < 0.0001) from the
uninduced control at 25 hpi. However, when expression of IncF-
APEX2 was induced with 5 nM aTc, sphingomyelin retention
was much less (20.84 ± 0.8516), a statistically significant
difference (p < 0.0001) from both uninduced controls at 14.5
and 25 h post-infection (Figure 4B). In comparison, 5 nM aTc
induction of IncATM-APEX2 or APEX2 alone resulted in slightly
smaller inclusions (Figure 4A), which were “less” bright (27.51
± 1.176 and 39.83 ± 0.6889, respectively) than the controls
at 25 h post-infection (36.79 ± 1.219 and 50.87 ± 0.8435,
respectively), a difference that was measured to be statistically
significant (p < 0.0001). Of note, in comparing the amount
of fluorescent label retained in inclusions induced with 5 nM
aTc to express either IncF-APEX2 or IncATM-APEX2, there
was a statistically significant decrease between organisms in
inclusions that were overexpressing IncF-APEX2 and IncATM-
APEX2 (20.84 ± 0.8516 vs. 27.51 ± 1.176, respectively; p <
0.0001), and a statistically significant decrease between organisms
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in inclusions that were overexpressing IncF-APEX2 and APEX2
only (20.84 ± 0.8516 vs. 39.83 ± 0.6889, p < 0.0001). Consistent
with our previous data, overexpression of these constructs likely
has a metabolic cost that negatively impacts the development of
the inclusion compared to uninduced controls. Yet, these data
are consistent with the notion that overexpression of specific
Incs may be deleterious to inclusion formation and development.
Specifically, our data indicate that, in addition to the smaller sized
inclusions formed after overexpression of IncF, the inclusion is
impaired in its interactions with host pathways.
Proximity Labeling of the Chlamydial
Inclusion Membrane
The expressed goal of our study was to design a tool to
allow the dynamic characterization of the inclusion membrane
interactome. In the process, we found that overexpression of one
of our Inc constructs negatively impacted inclusion development.
While this is interesting from the perspective of learning how
potential abnormalities impact chlamydial inclusion membrane
organization and Inc interactions, there is a risk of not having a
baseline “normal” for rigorous comparison. Therefore, we chose
to optimize proximity labeling conditions with our IncF-APEX2
strain using induction conditions that did not cause significantly
smaller inclusions, overt stress to the organisms (via loss of
plasmid), or significant issues interacting with host cell pathways,
as measured by Golgi-derived sphingomyelin retention. To test
our ability to label the inclusion membrane with biotin-phenol,
we infectedHeLa cells with Ctr IncF-APEX2 (Figure 5A) or wild-
type Ctr serovar L2 (Figure 5B). Uninfected HeLa cells were
included to determine background biotinylation activities within
the parameters of our experimental conditions (Figure 5C).
Seven hours post-infection, we induced expression of IncF-
APEX2with concentrations of aTc (0.2 nM) found to have limited
negative effects on Chlamydia. 26.5 h post-infection, monolayers
were labeled or not with biotin-phenol for 30 min at 37◦C. All
monolayers were treated with H2O2, which catalyzes the labeling
reaction, for an additional minute, as described in the Materials
and Methods. The reaction was quenched and the cells were fixed
in methanol and processed for immunofluorescence to detect
expression of the construct, labeling of subcellular structures
with biotin-phenol, and the inclusion membrane. As shown in
Figure 5A, 0.2 nM aTc induces the expression of IncF-APEX2,
and it was localized to the chlamydial inclusion membrane as
previously seen (Figure 1). Further, addition of biotin-phenol
resulted in labeling of the inclusion membrane: streptavidin-
488 reacted most strongly with the inclusion membrane, and
the staining colocalized with IncF-APEX2 and IncA. When no
biotin-phenol is added to the medium, there is no biotinylation
of the inclusion membrane or other subcellular structures in
the presence of IncF-APEX2. Likewise, when IncF-APEX2 is
not expressed and biotin-phenol is added to the medium,
there is no labeling of the inclusion membrane or other
subcellular compartments. These results were recapitulated using
the IncATM-APEX2 construct (Supplemental Figure 4). HeLa
cells infected or not with wild-type Ctr serovar L2 treated with 0.2
nM aTc and labeled with biotin-phenol did not result in labeling
of the inclusion membrane or other subcellular compartments
with biotin (Figures 5B,C), indicating that our experimental
conditions, as outlined in Materials and Methods, provide
minimal to no fluorescence background in these biochemical
reactions. Expression of IncF-APEX2 in combination with
addition of biotin-phenol to the medium resulted in specific
biotinylation of the chlamydial inclusion membrane.
Determination of Solubilization Conditions
for Extraction of Inclusion Membrane
Associated Proteins
One of the greatest difficulties in acquiring biochemical protein-
protein interaction data from an inclusion is the inherent
hydrophobicity of the Incs. In a separate study using proximity
labeling with biotin to capture chlamydial interacting partners
of eukaryotic proteins that localize to the chlamydial inclusion,
we identified other eukaryotic proteins that localize to the
chlamydial inclusion but failed to identify chlamydial binding
partners (Rucks and Srinivasan, unpublished data). In our initial
studies, we examined the biotinylation patterns from lysates
representative of 5 different conditions of HeLa cells infected
or not with Ctr pASK_L2_IncF-APEX2 uninduced with biotin-
phenol (negative for construct expression, therefore negative for
biotinylation), Ctr pASK_L2_IncF-APEX2 induced with 0.2 nM
aTc with biotin-phenol (positive for construct expression and
biotinylation), Ctr pASK_L2_IncF-APEX2 induced with 0.2 nM
aTc without biotin-phenol (positive for construct expression, but
negative for biotinylation), and Ctr serovar L2 or uninfected
HeLa cells treated with 0.2 nM aTc with biotin-phenol (absolute
negative controls) (as in Figure 5). IncF-APEX2 expression
is detectable by indirect immunofluorescence (Figures 1, 5)
but not by Western blot using either an anti-FLAG-M2 or
anti-IncF antibodies (data not shown). In our initial lysis
conditions, the bulk of the biotinylation was detected in the
pellets of cleared supernatants (data not shown). To increase
the solubility of transmembrane proteins, we increased detergent
concentrations of the lysis buffer. We prepared lysates from the 5
conditions described above, and as described in theMaterials and
Methods, and blotted for (i) GM130, a eukaryotic transmembrane
Golgi protein (Figure 6A), (ii) chlamydial Hsp60, a cytosolic
chlamydial protein (Figure 6B), (iii) IncA, a chlamydial inclusion
membrane protein (Figure 6C), (iv) tubulin, a eukaryotic
cytoskeletal protein (Figure 6D), and (v) streptavidin, to
monitor biotinylation within the samples (Figure 6E). Of note,
the eukaryotic and chlamydial transmembrane proteins were
detected within the cleared lysates but not within the pellets
(Figures 6A,C). Further, the streptavidin detected the bulk of the
biotinylated proteins within the cleared lysates from HeLa cells
infected with Ctr pASK_L2_IncF-APEX2 induced with 0.2 nM
aTc with biotin-phenol (Figure 6E, lane 3). We did detect some
biotinylation within uninduced samples from HeLa cells infected
with Ctr pASK_L2_IncF-APEX2 when treated with biotin-
phenol but detected no biotinylation from HeLa cells infected
with Ctr serovar L2, indicating that the background biotinylation
is likely from leaky expression of the construct and not inherent
background from the organisms (Figure 6E). Importantly, these
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FIGURE 5 | Monitoring biotinylation of the inclusion membrane after expression of IncF-APEX2. HeLa cells were infected with Ctr L2 transformant
IncF-APEX2 (A), or wild-type (not transformed) Ctr L2 (B) or mock infected (C). Expression of IncF-APEX2 was induced using 0.2 nM aTc at 7 h post-infection. As
described in Materials and Methods, at 27 hpi cells were labeled with biotin-phenol, fixed, and processed for indirect immunofluorescence to detect (from left to right):
construct expression with an anti-FLAG antibody (red), biotinylation using streptavidin-488 (green), and the inclusion membrane using an anti-IncA antibody (blue) or
DAPI (blue) to detect nuclei in uninfected cells. Negative controls (conditions not supportive of biotinylation of the inclusion membrane) in this study included Ctr
transformant IncF-APEX2 not induced for expression with biotin-phenol (A, top row), Ctr transformant IncF-APEX2 induced with 0.2 nM aTc without biotin-phenol (A,
bottom row), and wild-type Ctr L2 treated with both aTc and biotin-phenol (B), and mock infected HeLa (C). All images were taken with an Olympus Fluoview 1000
Laser Scanning Confocal Microscope (60x magnification with 2x zoom). Scale bars equal 10 µm. These images were obtained from coverslips that were removed
from the 6-well plates used to produce the data in Figure 6.
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FIGURE 6 | Lysis conditions compatible with solubilization of inclusion membrane proteins and pulldown of biotinylated proteins. HeLa cells seeded in
6-well plates were infected with Ctr L2 transformant IncF-APEX2, wild-type Ctr L2, or mock infected with the aTc induction/treatment conditions, followed by the
biotin-phenol additions as indicated. The cells remaining in the 6-well plates were lysed as described in the Materials and Methods, and cleared lysates (lysates) and
the insoluble pellets (pellets) were resolved by SDS-PAGE, transferred to a PVDF membrane, and Western blotted for a transmembrane Golgi protein GM130 (A),
chlamydial heat shock protein 60 (cHsp60) (B), inclusion membrane protein IncA (C), eukaryotic cytoskeletal protein tubulin (D), and biotinylated proteins with
streptavidin (E). Cleared lysates were normalized for protein content and equal amounts of protein were added to magnetic beads conjugated to streptavidin to pull
down biotinylated proteins from lysates. Western blot analysis using a streptavidin conjugate of eluate and unbound fractions from the pulldowns are shown in (F) and
Coomassie stain of the PVDF membrane showing total protein in (G).
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data indicate that we have determined lysis conditions capable of
solubilizing membrane proteins and, specifically, proteins within
the chlamydial inclusion membrane.
To confirm that the increased detergents did not interfere
with the pulldown of biotinylated proteins, we incubated these
lysates with magnetic streptavidin beads and resolved the
resulting eluates and unbound fractions by Western blot. As
shown in Figure 6F, most of the biotinylated proteins were
detected in the eluate fraction of HeLa cells infected with Ctr
pASK_L2_IncF-APEX2 induced with 0.2 nM aTc with biotin-
phenol. Importantly, very few biotinylated proteins were detected
in the unbound fraction of this sample, despite a significant
number of proteins transferred to the membrane, as indicated by
Coomassie Blue staining (Figure 6G). Of note, we also detected
some biotinylated proteins in the eluate fraction of HeLa cells
infected with Ctr pASK_L2_IncF-APEX2 not induced with aTc
but incubated with biotin-phenol. These results are consistent
with the background noted in the lysates of these samples
and likely due to leaky expression of the construct, as this
similar pattern is not observed in eluates of untransformed
Ctr. In all lysate and eluate fractions, we observed reaction
of the streptavidin conjugate with a 70 and 125 kDa protein
band (Figures 6E,F). Based on other studies in the laboratory,
these contaminants are likely from HeLa cells, as we see them
in unlabeled, uninfected HeLa cells. Consistent with these
observations are other studies identifying endogenous eukaryotic
biotin-binding proteins, which include pyruvate carboxylase
(∼125 kDa) and mitochondrial 3-methylcrotonyl carboxylase
(∼75 kDa) (Praul et al., 1998; Tytgat et al., 2015). However,
in the eluate fractions obtained from samples containing
these non-specific biotin-binding proteins (lanes 1, 4, and 5,
Figure 6F), these were the only two bands that appeared in
the eluate fraction, indicating that the pulldown protocol is
conducive toward specific binding of biotinylated proteins. In
conclusion, the lysis conditions support (i) the solubilization
of proteins found in the inclusion membrane and (ii) the
retention of biotinylated proteins from streptavidin beads in
the presence of elevated detergent concentrations. Therefore,
we have successfully developed tools to answer experimental
questions on the composition of, and specific interactions within,
the inclusion membrane.
DISCUSSION
From the moment of its entry into a host cell, the chlamydial
EB is enclosed in a membrane-bound vacuole. Within this
vacuole, the EB differentiates into an RB, which engages
transcription and translation to produce proteins that facilitate
the establishment of the chlamydial intracellular niche, the
inclusion. The membrane that encloses the inclusion resembles
a plasma membrane initially, but the ultimate remodeling of it
results in a membrane that highly resembles an exocytic Golgi
vesicle (Hackstadt et al., 1995, 1996; Moore et al., 2008). After
trafficking to the microtubule-organizing center, the inclusion
maintains the ability to form intimate connections with the
endoplasmic reticulum (Derre et al., 2011; Elwell et al., 2011) and
interacts selectively with other subcellular compartments such as
the slow transferrin recycling pathway (Ouellette and Carabeo,
2010). As the developmental cycle progresses and chlamydiae
multiply exponentially, the inclusion membrane grows in size
to accommodate the increasing numbers of organisms (Ward,
1988). This process requires new lipids for the membrane while
maintaining the ability of the inclusion to evade intracellular
host defenses. Remarkably, the recruitment of host cell resources
occurs across the inclusion membrane. A vast array of host
proteins has been found to localize to the chlamydial inclusion,
including Rab GTPases (Rzomp et al., 2003, 2006; Rejman
Lipinski et al., 2009; Capmany and Damiani, 2010), which are
important signaling proteins in vesicular trafficking, SNAREs
(Moore et al., 2011; Kabeiseman et al., 2013; Lucas et al., 2015),
which are important for membrane fusion events, and host lipid
metabolism proteins (Cox et al., 2012, 2016; Recuero-Checa et al.,
2016), which are important for the synthesis of lipids within the
inclusion.
We have previously proposed that the inclusion acts as a
pathogen-specified parasitic organelle, as increasing numbers of
reports indicate that there is trafficking between the host cell
and the chlamydial inclusion that may limit the impact of the
chlamydial organisms on the host cell (Moore and Ouellette,
2014). As key chlamydial proteins at the host-pathogen interface,
Incs make up 6% of a highly reduced genome, highlighting their
importance to chlamydial fitness. Given that, over the course of
the developmental cycle, Chlamydia shifts its nutritional sources
(Ouellette and Carabeo, 2010), these shifts in nutrient acquisition
may be the result of turnover or insertion of key Inc proteins in
the inclusion membrane (Ouellette et al., 2011). To understand
basic properties of the chlamydial inclusion, it is thus essential to
acquire a greater understanding of Inc proteins. However, many
questions remain about the basic properties of the chlamydial
inclusion due to the difficulty in purifying to homogeneity this
fragile compartment. Which Incs are absolutely required for
inclusion membrane establishment, expansion, and maintenance
remain unknown.
Based on data in the field, we hypothesize that Incs function
collaboratively to maintain the integrity and establishment of
the chlamydial inclusion. In this context, small Incs organize
the chlamydial inclusion membrane and larger Incs interface
with host cell machinery. The structure of Incs includes an N-
terminus, which contains the type III secretion signal sequence
and is typically less than 40 amino acids in length, followed
by at least two transmembrane domains and a C-terminus,
which ranges in size from 14 to 300 amino acids. These C-
terminal portions of Incs are hypothesized to be exposed to
the host cytosol (Rockey et al., 1997; Bannantine et al., 1998),
although the orientation of most Incs has not been specifically
examined. Implicit in our hypothesis is the assumption that Inc
cytosolic domains of less than 30 amino acids are too small to
favor interaction with or recruitment of host proteins. Rather,
these small Incs would favor interaction with neighboring Incs
in the context of the inclusion membrane. Other biological
membranes contain membrane proteins that form scaffolds to
support other protein-protein interactions, so-called membrane
microdomains. There are reports to suggest that Inc proteins may
form membrane microdomains within the inclusion membrane
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(Alzhanov et al., 2009; Mital et al., 2010, 2013;Weber et al., 2015).
In the context of one membrane microdomain, as defined by
IncB (CT232), CT101, CT222, and CT850 (Mital et al., 2010),
the C-terminal domains of these Incs consist of 24, 14, 38, and
290 amino acids, respectively. Therefore, consistent with our
hypothesis, IncB and CT101 may form scaffolding to stabilize
CT850 and CT222 in the inclusion membrane to facilitate
their interaction with host proteins. A separate study examining
Inc-Inc interactions in a bacterial two-hybrid model (BACTH)
demonstrated that IncF, a small Inc, can homodimerize and also
associate with multiple different Incs (Gauliard et al., 2015).
Challenging our assumption that small Incs primarily interact
with one another are recent data demonstrating membrane
microdomains formed by IncC, CT223, CT224, and CT288,
which are all Inc proteins with large C-terminal domains that
colocalized with phosphorylated Src (Weber et al., 2015). Until
this study, there have been no tools to directly test our hypothesis
or to examine specific protein-protein interactions and how
proteins are organized in the inclusion membrane throughout
the chlamydial developmental cycle.
To study inclusion membrane organization, we developed
a number of inducibly expressed fusion constructs in Ctr to
allow proximity labeling of neighboring membrane proteins.
Specifically, these tools can be used to examine consequences
of overexpression of Inc proteins and/or for mapping the
chlamydial inclusion membrane. For our initial study, we
designed Inc-APEX2 translational fusions for IncF, IncA, and
IncATM, where the C-terminal cytosolic domain of IncA was
replaced with APEX2. IncF is expressed during the early stages
of the chlamydial developmental cycle and contains a small 14
amino acid C-terminal domain, whereas IncA is expressed during
the mid-stages of the chlamydial developmental cycle (Shaw
et al., 2000; Gauliard et al., 2015). In our studies, both constructs
localized to the chlamydial inclusion membrane after expression
was induced 7 h post-infection (Figure 1). However, localization
of the IncF-APEX2 construct to the inclusion membrane was
highly sensitive to the amount of aTc used. Higher concentrations
of aTc correlated with IncF-APEX2 aggregating outside of
the chlamydial inclusion membrane (Figure 1C), significantly
smaller inclusion diameter (Figure 2), loss of the plasmid
harboring incF-apex2 upon secondary infection (Figure 3), and
reduced sphingomyelin trafficking to the inclusion (Figure 4).
Collectively, these data indicate that overexpression of IncF is
deleterious to inclusion membrane development.
A caveat to these data is that smaller inclusion diameter and
loss of plasmid were noted with the Ctr strain expressing APEX2
alone after induction with 5 nM aTc, indicating that there is
a metabolic burden associated with intracellular expression of
APEX2. Notably, the inclusion diameters formed by organisms
expressing APEX2 compared to organisms expressing IncATM-
APEX2 decreased on average by 20%, and this change was
statistically significant (p < 0.0001), (Figure 2). In contrast,
the inclusion diameters formed by organisms expressing IncF-
APEX2 only compared to those of APEX2 or IncATM-APEX2
after induction with 5 nM aTc, significantly decreased by 47.3 or
57.7%, respectively (p < 0.0001) (Figure 2). These comparisons
are important when considering a possible connection to loss
of plasmid, and thus stress of overexpression of the proteins,
on the organism. 5 nM aTc induction of expression of APEX2
alone or IncF-APEX2 both resulted in loss of plasmid (Figure 3).
By examining these numbers, overexpression of APEX2 alone
creates a greater stress than IncF-APEX2 but likely for different
reasons. APEX2 alone does not contain a signal sequence to allow
the bacteria to secrete or expel the protein; hence overproduction
of APEX2 may be interfering with other normal bacterial
functions. Our data related to IncF-APEX2 indicate that, at 5
nM aTc induction, IncF-APEX2 is secreted but tends to aggregate
outside of the chlamydial inclusion. If it remains associated with
the inclusion, then the resulting diameters are incredibly small
(Figures 1C, 2), suggesting that inclusion membrane expansion
is inhibited and potentially creating a limiting environment
for chlamydial growth and development. To confirm these
interpretations, we intend to add the secretion signal of IncF to
APEX2 thus allowing secretion of APEX2 once it is expressed.We
anticipate in this scenario that, if APEX2 is secreted, it would be
less toxic to Chlamydia. Secondly, we intend to perform electron
micrograph analysis of the inclusions formed after induction of
IncF-APEX2 to examine chlamydial developmental forms under
these conditions.
In a recent study, Weber et al. induced the expression of
40 predicted Incs and localized more than half of them to the
inclusion membrane (Weber et al., 2015). A caveat to this study
is that a single concentration of aTc was used (10 ng/ml, which
is equivalent to 20 nM) and was presumably added at the time
of infection. Several of the Incs that the authors confirmed to be
localized to the chlamydial inclusion are endogenously expressed
during the early or middle of the chlamydial developmental cycle
(specifically CT135, CT224, and CT227). Of those that did not
localize to the chlamydial inclusion, induction of expression of
CT616 and CT789 resulted in aberrant Chlamydia, presumably
due to loss of the plasmid during expression (Weber et al.,
2015). These results are not dissimilar to what we observed
with overexpression of IncF-APEX2 with higher concentrations
of aTc. Further, two of the Incs that remained associated with
bacteria and did not localize to the chlamydial inclusion, CT195
and CT365, were type III secreted by the surrogate Yersinia
pseudotuberculosis (Weber et al., 2015). Little is known about the
specificity of type III secretory chaperones with their chlamydial
effectors, but it is conceivable that if these effectors are expressed
during later stages of the chlamydial developmental cycle, then
they may not be capable of being type III secreted during the
early part of the developmental cycle. The reverse would also be
true: early effectors expressed later in the developmental cycle
may not have the correct chaperone to mediate their secretion.
In support of this, we observed that expressing IncF-APEX2 at
24 h post-infection resulted in IncF-APEX2 remaining associated
with the bacteria and not localizing to the chlamydial inclusion
(Supplemental Figure 5). In our study, we expressed an early
Inc at 7 h post-infection, which is within the normal time of
endogenous expression. We saw different negative phenotypes
associated with overexpression of IncF-APEX2, particularly
when overexpression of IncATM-APEX2 did not cause similar
negative effects on chlamydial inclusion development (Figures 2,
4) and plasmid stability (Figure 3).
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In this study we have defined clear consequences on inclusion
membrane development by overexpressing IncF-APEX2. We
have also developed a tool to help us understand the mechanism
associated with overexpression of IncF limiting the expansion
of the chlamydial inclusion membrane. Before we can explore
protein-protein interactions that occur after overexpression of
IncF, we need to establish baseline interactions that are associated
with normal inclusion development, which is why we chose to
induce IncF-APEX2 with 0.2 nM aTc for the proximity labeling
studies. Under these conditions, IncF-APEX2 is expressed and
localized to the chlamydial inclusion membrane. Upon addition
of exogenous biotin-phenol and in the presence of H2O2, the
inclusion membrane is also biotinylated (Figure 5). The sample
associated with the most biotinylated proteins are samples where
IncF-APEX2 expression is induced in the presence of biotin-
phenol (Figures 6E,F). Importantly, to identify IncF binding
partners, we also created lysis conditions compatible with
solubilizing known Incs (Figure 6C), and these conditions are
compatible with streptavidin pulldown (Figure 6F). Ongoing
studies are aimed toward identifying IncF-interaction partners
with appropriate negative controls, via Western blot. A caveat
to these studies is that Incs are in low abundance compared
to the eukaryotic proteins, thus we are working to concentrate
eluates from larger sample sizes to detect Incs. In addition,
existing Inc antibodies have not performed well in our hands,
for Western blot protocols, and this will require troubleshooting.
We anticipate being able to confirm by mass-spectrometry
analysis the ability of IncF to homodimerize within the inclusion
membrane, as seen in BACTH studies (Gauliard et al., 2015),
and to characterize other potential IncF-binding partners via
this methodology. These can then be compared to interactions
identified when IncF-APEX2 is overexpressed with 5 nM aTc.
Are some of these Inc proteins excluded from the inclusion
membrane? Are other interactions favored? If IncF expression
is blocked or reduced, then what are the consequences and how
do these relate to the protein-protein interactions characterized
by the use of our APEX2 constructs? For the first time in
Chlamydia biology, we will be able to address these important
experimental questions and identify key proteins involved in
inclusion membrane biogenesis, maintenance, and integrity.
AUTHOR CONTRIBUTIONS
ER and SO conceived the experimental ideas, directed their
completion. ER wrote the majority of the manuscript with MO
writing the Materials and Methods. MO, LJ, and RS completed
the experiments. SO, MO, LJ, and RS edited the manuscript.
ACKNOWLEDGMENTS
We would like to thank Emilie Gauliard, Kyle Kennedy, and
Ethan Thompson for their technical assistance. We would also
like to thank Drs. Ted Hackstadt (NIAID, RML, Hamilton,
MT) for antibodies and Rick Morrison (University of Arkansas
Medical Center, Little Rock, AR) for the chlamydial HSP60
antibody. We are appreciative to Dr. P. Scott Hefty (Kansas
University) for sharing his inducible expression chlamydial
plasmid, pASK_GFP_mKate2_L2. This work was supported by
NIAID R15AI107727-01A1 and R01AI114670-01A1 to ER, and
USD SSOM start-up funds to SO.
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found
online at: http://journal.frontiersin.org/article/10.3389/fcimb.
2017.00040/full#supplementary-material
Supplemental Figure 1 | Schematic illustration of APEX2 constructs.
Graphical representation of APEX2, IncA-APEX2, IncATM-APEX2, and
IncF-APEX2 with amino acid positions indicated for Incs (gray), transmembrane
domain (TM, white), single FLAG epitope tag (red), and APEX2 (blue). TM domains
were determined using TopCons (http://topcons.cbr.su.se/pred/). The diagrams
are not drawn to scale.
Supplemental Figure 2 | Inducible expression of IncA-APEX2 in Ctr L2.
HeLa cells were infected with Ctr L2 transformed with pASK_L2 containing
IncAfl-APEX2 (fl = full length), and 7 h post-infection construct expression was
induced with 5 nM anhydrotetracycline (aTc). Twenty four hour post-infection, cells
were fixed and processed for indirect immunofluorescence to detect construct
expression with an anti-FLAG antibody (red), inclusion membrane with an
anti-IncA antibody (green), and nuclei and chlamydial organisms with DAPI (blue).
Coverslips were imaged with an Olympus Fluoview 1000 Laser Scanning Confocal
Microscope (60x magnification with 2x zoom). Scale bars equal 10 µm.
Supplemental Figure 3 | Comparison of normal and aberrant chlamydial
forms by indirect immunofluorescence microscopy. HeLa cells were infected
with C. trachomatis serovar L2 or Ctr L2 transformed with pASK_L2_IncF-APEX2.
IncF-APEX2 expression was induced with addition of 5 nM anhydrotetracycline
(aTc) 7 h post-infection. Monolayers were fixed at 24 h post-infection and
organisms were stained with an anti-Ctr L2 antibody, followed by a secondary
conjugated to Alexa Fluor- 488 (WT) or 405 (IncF-APEX2). Penicillin will inhibit
chlamydial cell division and is used as the selecting agent for transformation;
organisms containing the plasmid will be insensitive to penicillin treatment.
Monolayers infected with C. trachomatis serovar L2 without the addition of
penicillin show inclusions with typical chlamydial developmental forms (≤1 µm). In
contrast, monolayers infected with C. trachomatis serovar L2 and treated with
penicillin show enlarged, aberrant development forms, consistent with a blockage
in cell division. Similar aberrant developmental forms are noted after expression of
IncF-APEX2 with 5 nM aTc; in these images, the transformants have lost the
plasmid in response to overexpression of IncF-APEX2. Select aberrant chlamydial
forms are denoted with white arrows. Scale bars equal 10 µm.
Supplemental Figure 4 | Biotin labeling of inclusion membrane by Ctr L2
IncATM-APEX2. HeLa cells were seeded on coverslips and infected with Ctr L2
IncATM-APEX2 transformant. 7 hpi, cells were either uninduced or induced with 5
nM aTc. 40 h post-infection, cells were either labeled for 30 min with biotin-phenol
(BP) or not, then treated with H2O2 to catalyze biotinylation of neighboring
proteins. Cells were fixed in methanol and processed for immunofluorescence to
detect IncATM-APEX2 (red), biotinylation (green), and the inclusion and nuclei
(blue).
Supplemental Figure 5 | Induction of IncF-APEX2 at different time points
post-infection with Ctr L2. HeLa cells were infected with Ctr L2 IncF-APEX2
transformants, and 5 nM anhydrotetracycline (aTc) was used to induce expression
of the construct at 3, 7, 12, 24, and 30 h post-infection. Cells were fixed and
processed for indirect immunofluorescence to detect the expression of construct
with an anti-FLAG antibody (red) or the inclusion membrane with an anti-IncA
antibody (green). Images were taken at 40X magnification with an Olympus BX60
mounted with a Nikon DS-Qi1MC digital camera. Scale bars equal 10 µm.
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